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Light-controlled thrombin catalysis and clot
formation using a photoswitchable G-quadruplex
DNA aptamer†
Aysha Ali,a Gemma A. Bullen,a Benjamin Cross,a Timothy R. Daﬀorn,b
Haydn A. Little,a Jack Manchester,a Anna F. A. Peacock a and
James H. R. Tucker *a
The reversible photocontrol of an enzyme governing blood coagulation
is demonstrated. The thrombin binding aptamer (TBA), was rendered
photochromic by modification with two anthracene groups. Light-
triggered anthracene photodimerisation distorts its structure, inhibiting
binding of the enzyme thrombin, which in turn triggers catalysis and the
resulting clotting process.
External control of biomolecule function is important for
regulating biological processes that are relevant to various
therapeutic and diagnostic applications. Photoregulation is a
popular method of control due to the high level of specificity
gained without the use of additional chemical reagents,1 with
photoswitchable groups allowing properties to be controlled in
a reversible manner. As part of ongoing interest in this area,
there are now a number of examples of diﬀerent photoactive
groups used for photocontrollable catalysis.1a,2,3 Here, through the
use of a photoswitchable DNA aptamer that displays anthracene
photochromism, we demonstrate a new way of using light to
reversibly control a catalytic process.
Human a-thrombin, an enzyme from the family of serine
proteases, is a key biological protein involved in the process of
blood coagulation at the site of a blood vessel injury.4 It has two
anion binding exosites, one of which (exosite I) binds fibrinogen.
During the formation of a blood clot, thrombin catalyses the
production of insoluble fibrin polymers from soluble fibrinogen
monomers. DNA aptamers, short single stranded oligonucleotides
generated synthetically to bind proteins and small molecules, are
widely used for a range of applications linked to diagnostics and
therapy.5 The thrombin binding aptamer or TBA (Fig. 1) is a 15-mer
that adopts an anti-parallel G-quadruplex (G4) tertiary structure
in the presence of K+ ions and binds to thrombin at exosite I,
the fibrinogen binding site.6,7 The resulting complex competi-
tively inhibits the binding of the enzyme to fibrinogen, thereby
inhibiting the process of blood coagulation. This has led to the
consideration of TBA and related compounds as treatments for
medical conditions linked to blood clotting disorders.5d However
the use of anticoagulants, including traditional ones (e.g. heparin or
warfarin), can often result in other healthcare risks.8 For example,
the reduction in systemic clotting capability couldmean that wound
healing is compromised at injury sites away from where anti-
coagulation is required. A dynamic system in which anticoagulation
could be deactivated locally using an orthogonal and external
source, and more quickly than the body’s clearance systems, could
provide an eﬀective solution to such an issue.
Previous examples exploring this idea using TBA derivatives2d, f,7b
have included azobenzene2d and nitrophenyl2f systems in which the
application of light was found to alter clotting times. Anthracene
photochromism is known to be particularly eﬀective in photo-
regulatory processes within supramolecular systems as its reversible
photodimerisation reaction can induce significant structural
changes.9 Here we show how it can be successfully applied for
the first time to a catalytic system by enabling thrombin-mediated
clotting to be controlled using light (Fig. 2).
Fig. 1 Structures of TBA and modified aptamers A1 and A2 depicting the
G4 quadruplex structure held together by H-bonds at guanine residues (in red)
and sequence variations (in blue) at positions X (in top loop) and Y (in bottom
loops); An denotes the anthracene connected to a D-threoninol linker.
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As part of our interest in photoregulated biological systems,10
we have previously demonstrated that DNA duplex formation can
be reversibly controlled by anthracene photodimerisation within
one DNA strand.10a We therefore decided on a similar synthetic
approach for this work by attaching anthracene to a D-threoninol
linker group via its C-9 position (Fig. 1), to enable its incorporation
into the TBA sequence using phosphoramidite chemistry. However
important considerations for the successful design of such a
photoswitchable system were firstly the position of the two
anthracene groups within the TBA sequence and secondly,
which bases they would replace. It was decided to retain those
guanines partaking in G-quadruplex formation as this motif
gives the required tertiary structure for strong thrombin binding.
Furthermore, it was reasoned that replacing thymines in both
TT loops would adversely aﬀect thrombin binding in its unphoto-
dimerised form as this bottom face binds to the protein.6
Therefore, one anthracene moiety was introduced into one TT
loop at the T12 position, with the other replacing a thymine at
T9 in the top TGT loop, giving the sequence A1. It was anticipated
that this strand would retain the ability to bind thrombin while at
the same time having two anthracene groups in close enough
proximity (i.e. separated by two bases) to undergo intramolecular
photodimerisation. In addition to A1, the sequence A2, containing
only one anthracene in the top loop at T9, was synthesised as a
control strand. Each strand was purified by reversed-phase HPLC
and characterised by ESMS (see ESI†).
To induce the desired anthracene photodimerisation, sam-
ples of A1 at 2 mM in aqueous buﬀer at pH 7.4 (10 mM KCl,
20 mM Tris HCl, 1 mMMgCl2, 120 mM NaCl, 2 mM CaCl2) were
subjected to photoirradiation (using a 365 nm bandpass filter)
over a period 4 hours. Over this time, the characteristic anthracene
absorbance band centred at ca. 370 nm was found to decrease by
73% (Fig. 3a), indicating successful photodimer formation.‡ In
contrast, the corresponding spectrum of sequence A2, containing
only one anthracene unit, hardly changed over the same time
period (Fig. 3b), confirming that the light-induced reaction was
predominantly an intramolecular process. Upon heating the
irradiated solution of A1 at 80 1C, the anthracene signal gradually
reappeared (67% reversion after 12 hours, see ESI†), with the
timescale and conditions for the reversion consistent with the
photocycloadduct from the forward reaction being predominantly
the head-to-tail isomer (Fig. 2).9b,10a
Circular dichroism (CD) spectra were recorded to assess the
extent to which the G-quadruplex tertiary structure of TBA was
aﬀected by anthracene modification and photodimer formation.
Although A1 gave amuch weaker spectrum than that of unmodified
TBA or the control A2, both derivatives gave characteristic signals of
a G4 structure,6,7 with positive peaks at 292 nm and 245 nm and a
negative peak at 261 nm for A1 (Fig. 4). The photoirradiated sample
of A1 gave an even weaker signal and slightly shifted peak maxima,
but with a pattern that also suggests a G4-type tertiary structure.
In order to probe the tertiary structures further, melting
temperature (Tm) values were determined using VT CD spectro-
scopy. In each case the data showed a single co-operative unfolding
transition (see ESI†), with the Tm value of 50 1C for TBA higher than
that of A1 (42 1C) but lower than that of A2 (56 1C). This indicates
that while the presence of one anthracene in the lower TGT loop is
stabilising, an additional anthracene in the top loop is destabilising.
However, while the photoirradiated sample of A2 gave only a small
change in Tm value (55 1C), that for the A1 sample rose to 52 1C after
photoirradiation. This increase in thermal stability can be explained
by the unfolding of the tertiary structure being hampered by the
presence of two intramolecular covalent crosslinks provided by the
anthracene photodimer.
Studies on the binding of thrombin to TBA and its modified
derivatives were undertaken using electromobility shift assays
(EMSAs). The open form of aptamer A1 was found to bind
thrombin, as shown by the appearance of DNA bands at the top
Fig. 2 Diagrammatic representation of anthracene photochromism in
aptamer A1 involving a [4p + 4p] photocycloaddition reaction, forming a
head-to-tail isomer. Distortion of the functionalised bottom loop, depicted in
bold, restricts thrombin binding, promoting catalysis and fibrin clot formation.
Fig. 3 Overlaid absorbance spectra (340–410 nm region) of a solution of
(a) aptamer A1 and (b) aptamer A2, showing the effect of photoirradiation
over a period of four hours (2 mM, pH 7.4).
Fig. 4 CD spectra of native TBA, aptamer A1 both before and after 4 h
photoirradiation and aptamer A2 (2 mM, pH 7.4).
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of the gel as a function of increasing concentration of the enzyme
(Fig. 5a). The location of these DNA bandsmatched those visualised
through protein stains, with the results similar to those for both
unfunctionalised TBA and A2 (see ESI†). These results show that
modification with either one or two anthracene groups does not
prevent binding to thrombin. However in contrast, the photo-
irradiated sample of A1 did not show any new DNA bands on the
EMSA under the same conditions (Fig. 5b).§ These results provide
good evidence for photo-switched binding arising through photo-
dimerisation of the two spatially separated anthracene units
(Fig. 2), which induces suﬃcient distortion of the G4 tertiary
structure within the modified aptamer to severely restrict its
binding properties. In support of these interpretations, the
heat-reverted sample of A1 was found to bind thrombin again,
confirming that the anthracene photochromism was responsible
for this behaviour (see ESI†). Furthermore, photoirradiation of a
solution of the control sample A2 had no detrimental eﬀect on its
ability to successfully bind thrombin due to its inability to form
intramolecular photoadducts (vide supra).
With photocontrolled binding of thrombin established, the
ability of light to control its catalytic activity was then investigated
using the Clauss assay (see ESI†), which measures changes in UV
transmission resulting from the polymerisation of fibrinogen to
the insoluble clotting product fibrin. The assay was first carried
out in the absence (as a control) and in the presence of the
unmodified aptamer TBA. As expected TBA inhibited thrombin’s
catalytic activity under these conditions, with fibrin formation
after an incubation time of 40 minutes reduced by 96% com-
pared to the control (Fig. 6). Experiments were then repeated
using A1 and A2, which revealed both to be almost as eﬀective as
TBA, with amounts of clotting product at 7% and 9% respectively
of the control. These results support the EMSA data, which
demonstrate eﬀective binding of these functionalised aptamers
to thrombin. However, repeating the assay in the presence of a
solution of photo-irradiated A1 indicated a significant increase in
activity, with the clotting product level raised to 73%. In contrast,
photoirradiation of A2 had no eﬀect on catalytic function. Finally,
also in good agreement with the UV/vis data and EMSA binding
studies, much of the original inhibitory activity of A1 could be
restored after heat treatment, with the level of clotting product
lowered again to 22%.
In conclusion, this work demonstrates the first application
of anthracene photochromism to the control of a catalytic
process in the form of thrombin catalysed fibrin clot formation.
While being relevant to the development of smart anticoagulation
therapies, such an approach also has the potential to be applied
more widely to other photopharmacological and optogenetic
processes.
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